-     America/New_York

Episode 4 - Supportive Pharmacotherapy for Prevalent Co-morbidities

Info Videos

Details

This activity is funded by Bayer AG and is not intended for a UK audience

Part IV of the course in pharmacotherapy in atrial fibrillation (AF) is exploring the fact that AF no longer is viewed as a solitary disease, but is strongly intertwined with a number of lifestyle conditions. The course will cover the relationships of AF to some of these conditions, and will provide evidence that lifestyle modifications per se can lead to better success rates in keeping patients in sinus rhythm whenever rhythm control strategy is chosen. Of course, this includes cardiovascular preventive pharmacotherapies for prevalent co-morbidities such as arterial hypertension, diabetes and heart failure.

Date

  -     America/New_York

59 people registered for this event

Sponsors

Dan Atar

A professor of cardiology at Oslo University Hospital in Oslo, Norway. Features in 8 videos on...

Read More

Marita Knudsen Pope

Marita Knudsen Pope is a MD at University Of Oslo, Institute of Clinical Medicine​, Dept. of...

Read More